Yao Yu
@yaoyu_md
Followers
213
Following
1K
Media
4
Statuses
124
Radiation Oncologist @sloan_kettering, @UCSF alum. Interested in cancers of the head and neck and CNS
Joined November 2018
RT @niseto: I’m happy to share our latest work on tumour necrosis! During my time in the @megeblad lab, we found that tumour necrosis is no….
nature.com
Nature - Neutrophils actively induce tumour necrosis, driving vascular occlusion, pleomorphic necrosis and metastasis.
0
70
0
RT @safaviaa: Led by Drs. Zakeri & @imrtlee, we report early @MSK_RadOnc exp w/ 40 Gy ENI + CCRT for larynx, HPX, p16- OPX + CUP, 97.3% pla….
0
12
0
RT @LarsVereecke: 🎉 Super excited to announce that our study "Colibactin-driven colon cancer requires adhesin-mediated epithelial binding"….
nature.com
Nature - The oncogenic potential of pks+ Escherichia coli depends critically on bacterial adhesion to host epithelial cells mediated by the type 1 pilus adhesin FimH and the F9 pilus adhesin FmlH.
0
20
0
RT @MSKCancerCenter: MSK radiation oncologist Dr. @yaoyu_md discusses how MSK is using #protontherapy to further advance treatment of CNS t….
mskcc.org
Learn how MSK doctors are using proton therapy to treat tumors of the brain and spinal cord.
0
4
0
RT @MTouatMD: 📢 Just published in JCO! What is the optimal chemotherapy for oligodendroglioma patients? Our study using data from the natio….
ascopubs.org
PURPOSEPatients with IDH-mutant 1p/19q-codeleted grade 3 oligodendroglioma (O3IDHmt/Codel) benefit from adding alkylating agent chemotherapy to radiotherapy (RT). However, the optimal chemotherapy...
0
31
0
RT @werr_li: Very happy to share our latest work on pulmonary carcinoids published in @JCO_ASCO:. TERT Expression and Clinical Outcome in P….
ascopubs.org
PURPOSEThe clinical course of pulmonary carcinoids ranges from indolent to fatal disease, suggesting that specific molecular alterations drive progression toward the fully malignant state. A similar...
0
5
0
RT @NeilWoodyMD: @CJTsaiMDPhD @sueyom @NRGonc @ASTRO_org @imrtlee I think one the big takeaways from HN 005 is that we need better prognost….
0
3
0
RT @ColtonLadbury: @brandon_imber presented on how radiation as a bridging therapy is particularly good at cytoreducing disease and improvi….
0
4
0
RT @imrtlee: @DrewMoghanaki @NRGonc @KaramLab @finn_corinne Not surprised. I’ve been preaching this for years based on Javelin HN100 resul….
0
2
0
RT @Chris_JacksonMD: Are spinal metastases from certain types of cancers more sensitive or more resistant to spine SBRT? Come to the quick….
0
2
0
RT @Chris_JacksonMD: Interested in hearing about a dosimetric analysis of 1904 3-fraction spine SBRT cases at @MSK_RadOnc to identify a new….
0
6
0
RT @xrtGenomics: FMISO PET is often criticized for having low signal-to-noise. Great work from @rickwraymd & Heiko Schoeder shows that trai….
jnm.snmjournals.org
Tumor hypoxia, an integral biomarker to guide radiotherapy, can be imaged with 18F-fluoromisonidazole (18F-FMISO) hypoxia PET. One major obstacle to its broader application is the lack of standardi...
0
6
0
RT @xrtGenomics: Our paper on a new approach to precision radiotherapy -- “Genotype-Directed Synthetic Cytotoxicity of ATR Inhibition with….
aacrjournals.org
AbstractPurpose:. The importance of the DNA damage response in mediating effects of radiotherapy (RT) has galvanized efforts to target this pathway with radiosensitizers. Yet early clinical trials of...
0
11
0
RT @CJTsaiMDPhD: A very thoughtful opinion piece by @imrtlee @MSK_RadOnc @lucmorrisnyc @max_diehn outlining the caveats of using TTMV-HPV D….
0
23
0
RT @xrtGenomics: @ProtonStorey @CJTsaiMDPhD @KaramLab @seanmmcbride @imrtlee I think two separate ideas are getting confused — 30gy definit….
0
6
0
RT @CJTsaiMDPhD: Cannot wait to hear more details about this important trial. 4:45PM CDT!. @PercyLeeMD @IyengarPuneeth @NRGonc @xrtGenomics….
0
5
0
RT @imrtlee: @DrMLChua @xrtGenomics @CJTsaiMDPhD @DanielMaMD Regardless all phase 2 trials should lead to phase 3. Our FMISO 30 Gy work is….
0
4
0
RT @DrMLChua: We are constantly innovating our RT contouring for #headneckcancers #HPVOPC #NPC . Another collaboration with a detailed atla….
0
19
0
RT @MSK_RadOnc: ☢️@JCO_ASCO: Of 152 analysable pts, 128 had nonhypoxic tumors & received 30Gy w chemo instead of SOC 70Gy. Hypoxia driven d….
0
20
0